Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs) tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations

Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs) : tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations

Copyright © 2020. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 214(2020) vom: 15. Mai, Seite 108395
1. Verfasser: Gremese, Elisa (VerfasserIn)
Weitere Verfasser: Alivernini, Stefano, Ferraccioli, Edoardo Sean, Ferraccioli, Gianfranco
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review CPI Immuno-rheumatologic related adverse events(irAEs) Loss of tolerance Tolerance Antineoplastic Agents, Immunological B7-H1 Antigen CD274 protein, human CTLA-4 Antigen mehr... CTLA4 protein, human PDCD1 protein, human Programmed Cell Death 1 Receptor Tumor Suppressor Proteins Abatacept 7D0YB67S97
Online verfügbar Volltext